Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11964961 Heteroaromatic compounds and their use as dopamine D1 ligands

Patent 11964961 was granted and assigned to Pfizer on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Steven Victor O'Neil0

Scot Richard Mente0

Amy Beth Dounay0

Chewah Lee0

Bruce Nelsen Rogers0

Ivan Viktorovich Efremov0

Lei Zhang0

Jaclyn Louise Henderson0

...

Date of Patent

April 23, 2024

0

Patent Application Number

172040950

Date Filed

March 17, 2021

0

Patent Citations

US Patent 8748621 1,3-disubstituted 4-(aryl-X-phenyl)-

0

US Patent 9107923 Heteroaromatic compounds and their use as dopamine D1 ligands

0

US Patent 9133190 Heteroaromatic compounds and their use as dopamine D1 ligands

0

US Patent 9139561 Heteroaromatic compounds and their use as dopamine D1 ligands

0

US Patent 9527831 Heteroaromatic compounds and their use as dopamine D1 ligands

0

US Patent 10421744 Heteroaromatic compounds and their use as dopamine D1 ligands

0

US Patent 9822097 Heteroaromatic compounds and their use as dopamine D1 ligands

0

US Patent 7101883 Uracil derivatives as inhibitors of TNF-α converting enzyme (TACE) and matrix metalloproteinases

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11964961 Heteroaromatic compounds and their use as dopamine D1 ligands

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool